06
Apr

High-profile U.K. investor Neil Woodford is putting more chips on the controversial Northwest Biotherapeutics, betting another $40 million on the company as it works through Phase III with a cancer vaccine.

…read more

Source: Woodford pours another $40M into Northwest Bio and its brain cancer vaccine

    

0 No comments